Results of Surveying Cardiologists and Clinical Pharmacologists on the Selection and the Efficacy and Safety Evaluation of Pharmacotherapy for Cardiovascular Diseases
The state policy for the safety of medicinal products involves analysis of specialists' competence in identifying adverse drug reactions (ADRs) during the use of medicinal products. It is of particular importance for the group of essential medicines, including those used in cardiology.The aim o...
Main Authors: | Yu. R. Bolsunovskaya, V. V. Arkhipov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2022-12-01
|
Series: | Безопасность и риск фармакотерапии |
Subjects: | |
Online Access: | https://www.risksafety.ru/jour/article/view/282 |
Similar Items
-
THE RESULTS OF A SURVEY OF SURGEONS ON THE SAFETY OF PHARMACOTHERAPY
by: I. N. Ochakovskaya, et al.
Published: (2018-12-01) -
Safety profile of pharmacotherapy in paitionts with non-alcogolic fatty liver disease
by: E. I. Peresada, et al.
Published: (2019-05-01) -
EVALUATION OF SAFETY OF DRUG THERAPY IN CLINICAL PRACTICE
by: M. N. Kostyleva, et al.
Published: (2015-03-01) -
Review of Pharmacotherapy for Tinnitus
by: Sang Hoon Kim, et al.
Published: (2021-06-01) -
Efficacy and safety of using eslicarbazepine in treating focal epilepsy in clinical practice (based on international Euro-Esli study and personal experience)
by: I. A. Zhidkova, et al.
Published: (2020-11-01)